Published in Neurosci Lett on November 29, 2002
Pharmacogenetics of antipsychotic-induced weight gain. Psychopharmacology (Berl) (2004) 0.92
The promise and reality of pharmacogenetics in psychiatry. Psychiatr Clin North Am (2010) 0.92
Genetic variability of histamine receptors in patients with Parkinson's disease. BMC Med Genet (2008) 0.87
Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium. BMC Gastroenterol (2013) 0.85
Predictors and markers of clozapine response. Psychopharmacology (Berl) (2005) 0.82
Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo. Psychopharmacology (Berl) (2011) 0.80
Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studies. Schizophr Res Treatment (2010) 0.79
Lack of Association between rs2067474 Polymorphism in Histamine Receptor H2 Gene and Breast Cancer in Chinese Han Population. ScientificWorldJournal (2015) 0.76
Pharmacogenetics of antipsychotic treatment response and side effects. Therapy (2010) 0.75
Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol (1995) 4.11
Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med (1998) 3.70
Pharmacogenetic prediction of clozapine response. Lancet (2000) 3.10
Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet (1995) 3.08
Association between 5-HT2A gene promoter polymorphism and anorexia nervosa. Lancet (1997) 2.83
General practitioners and incentives. BMJ (1993) 2.80
A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry (1996) 2.60
Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry (2001) 2.55
Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology (Oxford) (1999) 2.51
Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet (1992) 2.32
Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population. Heart (1999) 2.31
Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry (2009) 2.29
Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine. Acta Psychiatr Scand (2004) 2.24
Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. Br J Psychiatry (1999) 2.14
Can we prevent accidental injury to adolescents? A systematic review of the evidence. Inj Prev (1995) 1.96
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum (2000) 1.82
The diagnosis of emphysema. A computed tomographic-pathologic correlation. Am Rev Respir Dis (1986) 1.81
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum (1999) 1.75
Chlamydia: One step forward or two backwards? BMJ (1988) 1.75
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis (2006) 1.70
Dopamine receptors in the central thermoregulatory pathways of the rat. J Physiol (1978) 1.70
Dopamine D4 receptor subtypes and response to clozapine. Lancet (1993) 1.69
Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2000) 1.62
Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev (2006) 1.56
A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22). Am J Med Genet (1996) 1.55
Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2003) 1.52
Immunological studies on the mechanism of gold hypersensitivity reactions. Br Med J (1973) 1.50
Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation. J Neurol Neurosurg Psychiatry (2001) 1.50
Herpes simplex virus encephalitis: problems in diagnosis. Dev Med Child Neurol (1992) 1.48
Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder. Am J Psychiatry (1997) 1.47
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum (2001) 1.42
Two automated procedures for N-acetyl-beta-D-glucosaminidase determination evaluated for detection of drug-induced tubular nephrotoxicity. Clin Chem (1986) 1.38
Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. Am J Hum Genet (1999) 1.37
Urethral syndrome: a self limiting illness. Br Med J (Clin Res Ed) (1984) 1.33
Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus. J Neurochem (1999) 1.33
Comparison of methods to identify individuals at increased risk of coronary disease from the general population. BMJ (2003) 1.28
Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder. Mol Psychiatry (2003) 1.22
Lifetime course of eating disorders: design and validity testing of a new strategy to define the eating disorders phenotype. Psychol Med (2008) 1.22
Catechol-O-methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families. Psychiatr Genet (1997) 1.21
Haplotype association analysis of discrete and continuous traits using mixture of regression models. Behav Genet (2004) 1.20
Baclofen (beta-p-chlorophenyl-gamma-aminobutyric acid) enhances [3H]gamma-aminobutyric acid (3H-GABA) release from rat globus pallidus in vitro. J Pharm Pharmacol (1978) 1.19
Agglutinins to bacteria in Crohn's disease. Gut (1980) 1.19
Pre-formed articulating knee spacer in two-stage revision for the infected total knee arthroplasty. Int Orthop (2005) 1.18
Mutant bias in nonlethal selections results from selective recovery of mutants. Genetics (1991) 1.16
Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet (1987) 1.16
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum (1999) 1.16
Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Mol Psychiatry (1998) 1.13
Breakdown of pulse-labeled ribonucleic acid and polysomes in Bacillus megaterium: actions of streptolydigin, echinomycin, and triostins. Mol Pharmacol (1974) 1.11
Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families. Am J Med Genet (2000) 1.11
The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport (1996) 1.10
Linkage of Wolfram syndrome to chromosome 4p16.1 and evidence for heterogeneity. Am J Hum Genet (1996) 1.10
General practitioners' reasons for removing patients from their lists: postal survey in England and Wales. BMJ (2001) 1.09
Suggestive evidence for linkage of schizophrenia to markers on chromosome 13q14.1-q32. Psychiatr Genet (1995) 1.09
Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther (2001) 1.08
Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. Br J Pharmacol (2001) 1.08
Shifting services from secondary to primary care: stakeholders' views of the barriers. J Health Serv Res Policy (1999) 1.05
Suggestive evidence for linkage of schizophrenia to markers on chromosome 13 in Caucasian but not Oriental populations. Hum Genet (1997) 1.05
Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response. Schizophr Res (1998) 1.05
Abnormalities of Wnt signalling in schizophrenia--evidence for neurodevelopmental abnormality. Neuroreport (1998) 1.04
Intercalation of ethidium bromide into a triple-stranded oligonucleotide. Nucleic Acids Res (1991) 1.04
The impact of the CACNA1C gene polymorphism on frontolimbic function in bipolar disorder. Mol Psychiatry (2011) 1.03
Blebs produced by actin-myosin contraction during apoptosis release damage-associated molecular pattern proteins before secondary necrosis occurs. Cell Death Differ (2013) 1.02
The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis. Psychol Med (2009) 1.01
Quantitative computer-assisted osteodensitometry in total hip arthroplasty. Int Orthop (2006) 1.01
5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease. Hum Mol Genet (1998) 1.00
Rediscovering monoamine oxidase inhibitors. BMJ (1989) 1.00
Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Mol Psychiatry (1998) 1.00
Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase. J Neurosci (2001) 0.99
Initial evidence for the role of CACNA1C on subcortical brain morphology in patients with bipolar disorder. Eur Psychiatry (2011) 0.99
Probing the role of metal ions in the mechanism of inositol monophosphatase by site-directed mutagenesis. Eur J Biochem (1993) 0.98
Decreased expression of AMPA receptor messenger RNA and protein in AIDS: a model for HIV-associated neurotoxicity. Nat Med (1995) 0.96
Preliminary report of an association between measles virus and achalasia. J Clin Pathol (1983) 0.96
Growth and physical outcome of children conceived by in vitro fertilization. Pediatrics (1996) 0.96
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Health Technol Assess (2006) 0.96
Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival. Int J Cancer (1999) 0.94
Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev (2007) 0.94
Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortex. Acta Neuropathol (1999) 0.94
NHS Direct: consistency of triage outcomes. Emerg Med J (2003) 0.94
Inflammatory and immune response genes have significantly altered expression in schizophrenia. Mol Psychiatry (2012) 0.93
Eosinophilic enteritis: a rare cause of abdominal pain. Int J Colorectal Dis (2005) 0.92
A novel Shigella dysenteriae serovar isolated in Canada. J Clin Microbiol (2005) 0.92
Stimulus change contemporaneous with food presentation maintains responding in the presence of free food. Science (1973) 0.92
Mitochondria, cell surface, and carcinogenesis. Int Rev Cytol Suppl (1983) 0.92
A comparison of patient attitudes toward asthma self-management among acute and preventive care settings. J Asthma (1993) 0.91
Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance. Pharmacogenetics (2000) 0.91
Choline acetyltransferase variants and their influence in schizophrenia and olanzapine response. Am J Med Genet B Neuropsychiatr Genet (2007) 0.90
Impact of NHS Direct on other services: the characteristics and origins of its nurses. Emerg Med J (2002) 0.90
Systematic screening of the 14-3-3 eta (eta) chain gene for polymorphic variants and case-control analysis in schizophrenia. Am J Med Genet (2000) 0.89
No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene. Biol Psychiatry (1997) 0.89
Targeting high risk groups. Neighborhood organization for pediatric asthma management in the Neighborhood Asthma Coalition. Chest (1994) 0.89
Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease. Neuroreport (1997) 0.89
Epitope mapping of the NS4 and NS5 gene products of hepatitis C virus and the use of a chimeric NS4-NS5 synthetic peptide for serodiagnosis. J Virol Methods (1995) 0.89
Actinic granuloma of the conjunctiva. Br J Ophthalmol (2003) 0.89
Antibodies to influenza A in a cluster of children with juvenile chronic arthritis. Br J Rheumatol (1988) 0.88